The use of zolpidem in the treatment of progressive supranuclear palsy

Journal of Clinical Neuroscience

Volumn 17, Issue 3, 2010, Pages 385-386

  Cotter, C ^a   Armytage, T ^a   Crimmins, D ^a  

^a GOSFORD HOSPITAL   (Australia)

Author keywords

Ocular motility; Progressive supranuclear palsy; Quality of life

Indexed keywords

SENNA EXTRACT; VENLAFAXINE; ZOLPIDEM;

ADULT; ARTICLE; CASE REPORT; CONTROLLED DRUG RELEASE; DRUG FORMULATION; EVENING DOSAGE; EYE MOVEMENT; FACIAL EXPRESSION; HUMAN; MALE; MORNING DOSAGE; MOTOR PERFORMANCE; NEUROTRANSMISSION; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PSEUDOBULBAR PALSY; SACCADIC EYE MOVEMENT;

GABA AGONISTS; HUMANS; MALE; MIDDLE AGED; PYRIDINES; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 75349104161     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2009.05.038     Document Type: Article

References (8)

1. Steele J.C., Richardson J.C., and Olszewski J. Progressive supranuclear palsy: a heterogeneous degeneration involving the brainstem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10 (1964) 333-359
2. Agid Y., Javoy-Agid F., Rubery M., et al. Progressive supranuclear palsy: anatomical and biochemical considerations. In: Yahr M.D., and Bergman K.J. (Eds). Advances in neurology vol. 45 (1986), Raven Press, New York 191-206
3. Foster N.L., Minoshima S., Johanns J., et al. PET measures of benzodiazepine receptors in progressive supranuclear palsy. Neurology 54 (2000) 1768-1773
4. Levy R., Ruberg M., Herrero M., et al. Alterations of GABAergic neurons in the basal ganglia of patients with progressive supranuclear palsy: an in situ hybridisation study of GAD67 messenger RNA. Neurology 45 (1995) 127-134
5. Litvan I., and Chase T.N. Traditional and experimental therapeutic approaches. In: Litvan I., and Agid Y. (Eds). Progressive supranuclear palsy: clinical and research approaches (1992), Oxford University Press, New York 254-269
6. Mayr B., Bonelli R.M., Niederwieser G., et al. Zolpidem in progressive supranuclear palsy. Eur J Neurol 9 (2002) 184-185
7. Langer S.Z., Arbilla S., Scatton B.V., et al. Receptors involved in the mechanism of action of zolpidem. In: Sauvanet J.P., Langer S.Z., and Morselli P.L. (Eds). Imidazopyridines in sleep disorders: a novel experimental and therapeutic approach (1998), Raven Press, New York 55-70
8. Daniele A. Zolpidem in progressive supranuclear palsy. Correspondence. N Engl J Med 341 (1999) 543-544